Table 2.
KEGG pathway enrichment analysis results of genes significantly affected by the presence of pBCX01 at 37°C exponential phase.
| KEGG pathway | Observed gene count | No. of genes in pathway | False discovery rate |
|---|---|---|---|
| Positively affected by the presence of pBCX01 | |||
| Transmembrane | 98 | 984 | 3.02E-08 |
| Transmembrane helix | 96 | 973 | 4.14E-08 |
| Negatively affected by the presence of pBCX01 | |||
| Metabolic pathways | 72 | 657 | 4.14E-12 |
| Biosynthesis of antibiotics | 41 | 235 | 4.51E-12 |
| Biosynthesis of secondary metabolites | 47 | 320 | 1.09E-11 |
| Carbon metabolism | 22 | 117 | 5.36E-07 |
| Biosynthesis of amino acids | 23 | 140 | 1.85E-06 |
| Propanoate metabolism | 10 | 33 | 7.42E-05 |
| Microbial metabolism in diverse environments | 25 | 216 | 0.00013 |
| Fatty acid metabolism | 9 | 32 | 0.00027 |
| Valine, leucine and isoleucine degradation | 7 | 21 | 0.00076 |
| Butanoate metabolism | 8 | 29 | 0.00076 |
| Fructose and mannose metabolism | 5 | 16 | 0.0086 |
| Terpenoid backbone biosynthesis | 5 | 16 | 0.0086 |
A false discovery rate cut off or 0.01 was used to accept a significant enrichment of DEG in each group.